Search details
1.
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.
N Engl J Med
; 386(22): 2084-2096, 2022 06 02.
Article
in English
| MEDLINE | ID: mdl-35507508
2.
Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials.
Lancet
; 396(10261): 1491-1503, 2020 11 07.
Article
in English
| MEDLINE | ID: mdl-33065035
3.
Exposure to lead and vaccine-specific IgG titers in South African children participating in the Venda Health Examination of Mothers, Babies and their Environment (VHEMBE): A longitudinal study.
Environ Res
; 180: 108794, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31655331
4.
Prime-pull vaccination with a plant-derived virus-like particle influenza vaccine elicits a broad immune response and protects aged mice from death and frailty after challenge.
Immun Ageing
; 16: 27, 2019.
Article
in English
| MEDLINE | ID: mdl-31700523
5.
A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults.
Clin Immunol
; 168: 72-87, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-26987887
6.
Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.
J Infect Dis
; 212 Suppl 2: S379-83, 2015 Oct 01.
Article
in English
| MEDLINE | ID: mdl-25957963
7.
Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens.
Clin Immunol
; 154(2): 164-77, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25128897
8.
Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates.
J Virol
; 87(7): 3668-77, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23302894
9.
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans.
Sci Immunol
; 9(94): eadi8039, 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38579013
10.
Effects of polychlorobiphenyls, polybromodiphenylethers, organochlorine pesticides and their metabolites on vitamin A status in lactating grey seals.
Environ Res
; 120: 18-26, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23051620
11.
Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19.
NPJ Vaccines
; 8(1): 13, 2023 Feb 13.
Article
in English
| MEDLINE | ID: mdl-36781879
12.
Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development.
Front Immunol
; 14: 1166059, 2023.
Article
in English
| MEDLINE | ID: mdl-38077383
13.
Development and characterization of a plant-derived norovirus-like particle vaccine.
Vaccine
; 41(41): 6008-6016, 2023 09 22.
Article
in English
| MEDLINE | ID: mdl-37625992
14.
Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity.
NPJ Vaccines
; 7(1): 42, 2022 Apr 11.
Article
in English
| MEDLINE | ID: mdl-35410323
15.
A Hemagglutinin 1 Carrying Plant-Based Virus-like Particle Vaccine Generates an Efficacious Cellular Response by Exploiting IL-1 Signaling in Both Adult and Aged Mice.
Immunohorizons
; 6(6): 384-397, 2022 06 24.
Article
in English
| MEDLINE | ID: mdl-35750356
16.
Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals.
Front Immunol
; 13: 880784, 2022.
Article
in English
| MEDLINE | ID: mdl-35693815
17.
Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19.
Nat Commun
; 13(1): 6905, 2022 11 12.
Article
in English
| MEDLINE | ID: mdl-36371408
18.
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.
Cell Mol Immunol
; 19(2): 222-233, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34983950
19.
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities.
NPJ Vaccines
; 7(1): 142, 2022 Nov 09.
Article
in English
| MEDLINE | ID: mdl-36351931
20.
Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.
J Infect Dis
; 201(7): 1000-6, 2010 Apr 01.
Article
in English
| MEDLINE | ID: mdl-20170374